Firefly Neuroscience (AIFF) Other Non-Current Liabilities (2021 - 2025)
Firefly Neuroscience (AIFF) posted Other Non-Current Liabilities of $477000.0 for Q4 2025, down 42.32% on a QoQ basis from $827000.0 in Q4 2024, and down 42.32% year-over-year from $827000.0 in Q4 2024.
Analysis
Firefly Neuroscience (AIFF) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends
Firefly Neuroscience has reported Other Non-Current Liabilities for 4 years, with the latest figure at $477000.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 42.32% year-over-year to $477000.0 in Q4 2025; TTM through Dec 2025 was $477000.0, a 42.32% decrease from a year earlier, with the FY2025 full-year figure at $477000.0, down 42.32% from the prior year.
- Other Non-Current Liabilities was $477000.0 for Q4 2025 at Firefly Neuroscience, down from $827000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $2.3 million in Q1 2022, with the low at $477000.0 in Q4 2025.
- Average Other Non-Current Liabilities over 4 years is $1.2 million, with a median of $1.2 million recorded in 2021.
- The largest YoY upside for Other Non-Current Liabilities was 42.32% in 2025 against a maximum downside of 42.32% in 2025.
- Over 4 years, Other Non-Current Liabilities stood at $930000.0 in 2021, then surged by 49.94% to $1.4 million in 2022, then slumped by 40.69% to $827000.0 in 2024, then slumped by 42.32% to $477000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $477000.0 (Q4 2025), $827000.0 (Q4 2024), and $1.4 million (Q3 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 477,000.00 |
| Dec 31, 2024 | 827,000.00 |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 2.30 Mn |
| Dec 31, 2021 | 930,000.00 |